Stocks and Investing Stocks and Investing
Thu, June 2, 2022
Wed, June 1, 2022
Tue, May 31, 2022
Mon, May 30, 2022
Fri, May 27, 2022

David Nierengarten Maintained (SWTX) at Buy with Decreased Target to $50 on, May 27th, 2022


Published on 2024-10-27 21:19:46 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Decreased Target from $110 to $50 on, May 27th, 2022.

David has made no other calls on SWTX in the last 4 months.



There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $82 on, Tuesday, May 24th, 2022